[
  {
    "ts": "2025-11-29T18:28:58+00:00",
    "headline": "Jim Cramer Says He is “Particularly Fond” of Johnson & Johnson",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed, along with the need for diversification. Cramer highlighted that he is fond of the stock, as he said: “You could own JNJ and Merck with their incredible franchises. You know what? I’m actually particularly fond of JNJ right now. They’re spinning off their […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-particularly-fond-182858806.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5f6f2d8b-05a5-3166-b867-adc3f54ca618",
      "content": {
        "id": "5f6f2d8b-05a5-3166-b867-adc3f54ca618",
        "contentType": "STORY",
        "title": "Jim Cramer Says He is “Particularly Fond” of Johnson & Johnson",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed, along with the need for diversification. Cramer highlighted that he is fond of the stock, as he said: “You could own JNJ and Merck with their incredible franchises. You know what? I’m actually particularly fond of JNJ right now. They’re spinning off their […]",
        "pubDate": "2025-11-29T18:28:58Z",
        "displayTime": "2025-11-29T18:28:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/89e1f430fe28c1b8a95ed15a5f2121e9",
          "originalWidth": 1920,
          "originalHeight": 2880,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LMB4.cJ4QshLul1iafFeZw--~B/aD0yODgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/89e1f430fe28c1b8a95ed15a5f2121e9.cf.webp",
              "width": 1920,
              "height": 2880,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R1oW63qurpnb8_JVxKZy8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/89e1f430fe28c1b8a95ed15a5f2121e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-particularly-fond-182858806.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-particularly-fond-182858806.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-29T23:33:00+00:00",
    "headline": "Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%?",
    "summary": "The struggling pharmaceutical giant is showing signs of life.",
    "url": "https://www.fool.com/investing/2025/11/29/should-you-buy-this-blue-chip-pharmaceutical-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "5804f0ab-b5c4-3c17-ac3e-ceffaca09bd9",
      "content": {
        "id": "5804f0ab-b5c4-3c17-ac3e-ceffaca09bd9",
        "contentType": "STORY",
        "title": "Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%?",
        "description": "",
        "summary": "The struggling pharmaceutical giant is showing signs of life.",
        "pubDate": "2025-11-29T23:33:00Z",
        "displayTime": "2025-11-29T23:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/8e62fdca4c2fc9021c9e91fc85263db6",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor and patient talking.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iZqCucMfkueuFvyfprTxjQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/8e62fdca4c2fc9021c9e91fc85263db6.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lyqnKgHEH4Mg2qrS9yr_HA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/8e62fdca4c2fc9021c9e91fc85263db6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/29/should-you-buy-this-blue-chip-pharmaceutical-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-blue-chip-pharmaceutical-stock-233300900.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]